Patents by Inventor James II Stec

James II Stec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
    Publication number: 20030180770
    Abstract: The present invention is directed to the identification of markers that can be used to determine whether ovarian cancer is sensitive or resistant to a therapeutic agent. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with sensitivity or resistance to a therapeutic agent. Thus, by examining the expression of the individual markers of a marker set, also referred to as the expression profile of the marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of the ovarian cancer.
    Type: Application
    Filed: February 7, 2003
    Publication date: September 25, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Andrew I. Damokosh, Natalia Iartchouk, James II Stec, Edwin A. Clark, Karen Lu, Lynn Hartmann